These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26729968)

  • 21. Potential risks associated with high-dose valproate in pregnancy in psychiatric patients.
    Vajda FJ; Solinas C
    Aust N Z J Psychiatry; 2005 Jun; 39(6):526-7. PubMed ID: 15943661
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
    Sekhar S; Kalra B; Mendhekar DN; Tekur U
    J Clin Pharmacol; 2010 Jun; 50(6):688-92. PubMed ID: 20075184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of valproate plasma concentrations and dose in bipolar affective disorder.
    Perry PJ; Bever-Stille KA; Arndt S; Gundersen S
    J Clin Psychopharmacol; 2000 Apr; 20(2):277-9. PubMed ID: 10770477
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
    Young L; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
    [No Abstract]   [Full Text] [Related]  

  • 26. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
    Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
    BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproate-induced tinnitus misinterpreted as psychotic symptoms.
    Reeves RR; Mustain DW; Pendarvis JE
    South Med J; 2000 Oct; 93(10):1030-1. PubMed ID: 11147471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y; Annagur BB; Sayin AA; Akbaba N
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum Valproic Acid Levels During Initial Conversion of Antituberculoid Therapy in Bipolar Mania: A Case Report and Literature Review.
    DeLucia B; Mahon J
    Psychosomatics; 2017; 58(4):446-449. PubMed ID: 28413090
    [No Abstract]   [Full Text] [Related]  

  • 30. Pedal edema associated with addition of low-dose quetiapine to valproate treatment in bipolar disorder.
    Chen CY; Yeh YW; Kuo SC; Shiah IS; Liu PY; Chen CL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1551-2. PubMed ID: 19665043
    [No Abstract]   [Full Text] [Related]  

  • 31. Valproate in acute mania: is our practice evidence based?
    Vasudev K; Mead A; Macritchie K; Young AH
    Int J Health Care Qual Assur; 2012; 25(1):41-52. PubMed ID: 22455007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inadequate vasopressin secretion and valproate].
    Franco Hidalgo S; Prieto de Paula JM; Salado Valdivieso I
    Endocrinol Nutr; 2009 May; 56(5):277. PubMed ID: 19627751
    [No Abstract]   [Full Text] [Related]  

  • 33. Reproductive function and risk for PCOS in women treated for bipolar disorder.
    Rasgon NL; Altshuler LL; Fairbanks L; Elman S; Bitran J; Labarca R; Saad M; Kupka R; Nolen WA; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich G; Grunze H; Walden J; Post R; Mintz J
    Bipolar Disord; 2005 Jun; 7(3):246-59. PubMed ID: 15898962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective Analysis of Steady-State Sodium Valproate Plasma Concentrations in Chinese Patients With Bipolar Disorder: Impact of Demographic and Clinical Characteristics.
    Qiming Q; Ping Z; Huiqi L; Leyu X; LIren L; Ming L
    Ther Drug Monit; 2024 Oct; 46(5):658-663. PubMed ID: 38648661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divalproex in the treatment of bipolar disorder.
    Keck PE; McElroy SL
    Psychopharmacol Bull; 2003; 37 Suppl 2():67-73. PubMed ID: 15021862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate of Serum Valproate Concentration Monitoring in Patients with Bipolar Disorder Type I at Srinagarind Hospital Outpatient Clinic.
    Paholpak P; Paholpak S; Patanasethanant D; Rangseekajee P; Patjanasoontorn N
    J Med Assoc Thai; 2016 Oct; 99(10):1153-60. PubMed ID: 29952475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
    Martinez JM; Russell JM; Hirschfeld RM
    Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium valproate-induced pedal edema on chronic therapy: A rare adverse drug reaction.
    Prajapati H; Kansal D; Negi R
    Indian J Pharmacol; 2017; 49(5):399-400. PubMed ID: 29515282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
    Joffe H; Cohen LS; Suppes T; McLaughlin WL; Lavori P; Adams JM; Hwang CH; Hall JE; Sachs GS
    Biol Psychiatry; 2006 Jun; 59(11):1078-86. PubMed ID: 16448626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.